Only one patient will get access to this experimental ALS therapy before it’s approved

Discussion in 'Market News' started by sniper-academy, Jun 27, 2018.


Draft saved Draft deleted
  1. sniper-academy

    sniper-academy Administrator Staff Member

    Joined:
    Sep 30, 2011
    Messages:
    259,465
    Likes Received:
    5
    The drug would have cost more than $300,000 per patient, sparking criticism that its manufacturer planned to profit off dying patients.
    [​IMG]
    [​IMG] [​IMG] [​IMG] [​IMG]

    Continue reading...
     
Loading...

Share This Page